Activator protein-1 binding activities in discrete regions of rat brain after acute and chronic administration of methamphetamine

Journal of Neurochemistry

Volumn 67, Issue 2, 1996, Pages 708-716

  Ishihara, Takeshi ^a   Akiyama, Kazufumi ^a   Kashihara, Kenichi ^a   Ujike, Hiroshi ^a   Hamamura, Takashi ^a   Okada, Shoshiro ^a   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

AP 1 binding activities; Behavioral sensitization; Gel mobility shift assay; Methamphetamine; Supershift assay; Western blot analysis

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ETICLOPRIDE; METHAMPHETAMINE; SYNAPSIN I;

ABSTINENCE; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BINDING AFFINITY; CINGULATE GYRUS; CORPUS STRIATUM; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALIA;

EID: 0030056147     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67020708.x     Document Type: Article

References (22)

1. Akiyama K., Kanzaki A., Tsuchida K., and Ujike H. (1994) Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophr. Res. 12, 251-257.
2. Angel P. and Karin M. (1991) The role of Jun, Fos and the AP-I complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
3. 125I]iodosulpride. Neuroscience 20, 117-155.
4. Carter M. S. and Krause J. E. (1990) Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma. J. Neurosci. 10, 2203-2214.
5. Comb M., Birnberg N. C., Seasholtz A., Herbert E., and Goodman H. M. (1986) A cyclic AMP- and phorbol ester-inducible DNA element. Nature 323, 353-356.
6. Couceyro P., Pollock K. M., Drews K., and Douglass J. (1994) Cocaine differentially regulates activator protein-1 mRNA levels and DNA-binding complexes in the rat striatum and cerebellum. Mol. Pharmacol. 46, 667-676.
7. Douglass J., McMurray C. T., Garrett J. E., Adelman J. P., and Calavetta L. (1989) Characterization of the rat prodynorphin gene. Mol. Endocrinol. 3, 2070-2078.
8. Graybiel A. M., Moratalla R., and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87, 6912-6916.
9. Hope B., Kosofsky B., Hyman S. E., and Nestler E. J. (1992) Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. USA 89, 5764-5768.
10. Hope B. T., Kelz M. B., Duman R. S., and Nestler E. J. (1994a) Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14, 4318-4328.
11. Hope B. T., Nye H. E., Kelz M. B., Self D. W., Iadarola M. J., Nakabeppu Y., Duman R. S., and Nestler E. J. (1994b) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13, 1235-1244.
12. Hughes P. and Dragunow M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133-178.
13. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., and Bloch B. (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65, 1041-1050.
14. Nguyen T. V., Kosofsky B. E., Birnbaum R., Cohen B. M., and Hyman S. E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. USA 89, 4270-4274.
15. Paulson P. E., Camp D. M., and Robinson T. E. (1991) Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl.) 103, 480-492.
16. 1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution. J. Neurochem. 50, 451-463.
17. Robinson T. E. and Becker J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11, 157-198.
18. Ruskin D. N. and Marshall I. F. (1994) Amphetamine- and cocaine-induced Fos in the striatum depends on D2 dopamine receptor activation. Synapse 18, 233-240.
19. Schreiber E., Matthias P., Muller M. M., and Schaffner W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
20. Ujike H., Akiyama K., and Otsuki S. (1990) D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology (Berl.) 102, 459-464.
21. Ujike H., Kanzaki A., Okumura K., Akiyama K., and Otsuki S. (1992) Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci. 50, PL-129-PL-134.
22. Wang J. Q. and McGinty J. F. (1995) Alterations in striatal zif/ 268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration. Brain Res. 673, 262-274.